MDM2 and mantle cell lymphoma: Furthermore, JNJ-26854165 [serdemetan, a human double minute protein (HDM)-2 antagonist] induced cell death and inhibited cholesterol transport in mantle cell lymphoma (MCL) and multiple myeloma (MM) [8].